Siemens and Impac expand co-operation in oncology information
systems
20 August 2009
Siemens Healthcare is expanding its portfolio for cancer therapy by
partnering with Impac Medical Systems, Inc, part of the Swedish Elekta
Group, which includes an extension of its
software distribution agreement to 2016 and adding the Mosaiq software to its oncology
portfolio.
This
partnership with IMPAC will afford Siemens customers access to Impac’s
latest innovative
oncology information system (OIS) in addition to the radiation therapy
systems from
Siemens. Moreover, Siemens and IMPAC will work together to develop
interfaces between
Mosaiq and Iontris, making it possible to use Mosaiq with Siemens
particle therapy
solutions in the future.
Under the extended agreement, Siemens will offer the Mosaiq software as
its next generation
OIS offering to Lantis, the OIS currently sold by Siemens. Siemens
Lantis customers will have
the option of upgrading to Mosaiq or continuing to utilize their Lantis
systems. Siemens will
extend service support and application training for its customers to
include Mosaiq.
Mosaiq is an image-enabled electronic medical record for oncology that
allows documentation of
patient data, from diagnosis to therapy. Clinical images, lab results,
and external documents can
also be integrated. Support for additional business functions such as
scheduling, invoicing,
management reporting and analysis, among others, can also be
implemented.
"We have maintained a very successful partnership with Impac since 1992
in the area of oncology
information systems. In addition to cooperating on the development of
interfaces for our systems
for photon and electron radiation therapy, we are now working together
in particle therapy. We are
confident we will be able to offer our customers sustainable oncology
systems which help them to
optimize workflows and master the daily challenges of the hospital
routine," said Holger Schmidt,
CEO Oncology Care Systems, Siemens Healthcare.
"We are pleased to partner with Siemens and look forward
to continuing a long and mutually beneficial relationship. We are
certain Mosaiq will assist clinicians to efficiently manage even the
most demanding workflows in oncology enabling our customers to deliver
the best possible patient care," said Jay Hoey, IMPAC President and CEO.
Bookmark this page